益豐藥房(603939.SH):擬向銀行申請增加16.25億元授信額度
格隆匯9月29日丨益豐藥房(603939.SH)公佈,2022年9月29日,公司召開第四屆董事會第十九次會議,審議通過了《關於增加銀行綜合授信額度的議案》。
在第四屆董事會第十次會議與2021年年度股東大會審議《關於向銀行申請綜合授信額度並接受關聯方擔保的議案》的額度內,向長沙銀行常德鼎城支行、興業銀行長沙分行、光大銀行長沙友誼路支行、廣發銀行常德分行、華融湘江銀行長沙分行、民生銀行長沙分行合計增加16.25億元授信額度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.